BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magnan C, Le Stunff H. Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders. Mol Metab 2021;53:101298. [PMID: 34273578 DOI: 10.1016/j.molmet.2021.101298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sabnis RW. Modified Benzofuran-carboxamide Compounds as Glucosylceramide Synthase Inhibitors for Treating Diseases. ACS Med Chem Lett 2022;13:879-80. [DOI: 10.1021/acsmedchemlett.2c00182] [Reference Citation Analysis]
2 Meneyrol K, Estévez-Salguero Á, González-García I, Guitton J, Taouis M, Benomar Y, Magnan C, López M, Le Stunff H. Ovarian insufficiency impairs glucose-stimulated insulin secretion through activation of hypothalamic de novo ceramide synthesis. Metabolism 2021;123:154846. [PMID: 34371064 DOI: 10.1016/j.metabol.2021.154846] [Reference Citation Analysis]